logo
Plus   Neg
Share
Email

GM Turns To Profit In Q4; Results Beat Estimates

generalmotors-feb06-lt.jpg

General Motors Co. (GM) on Wednesday reported a profit for the fourth quarter, compared to a loss in the year-ago period that included a non-cash charge related to the U.S. tax reform. Both revenue and adjusted earnings per share for the quarter beat analysts' estimates. The automaker's shares are rising almost 4 percent in pre-market activity.

According to GM, the latest quarter's results were led by strong performance in GM North America, including strong pricing for GM's all-new full-size pickup trucks - the Chevrolet Silverado and GMC Sierra.

Fourth-quarter net income attributable to GM common stockholders was $2.01 billion or $1.40 per share, compared to net loss of $5.17 billion or $3.65 per share in the year-ago period.

The year-ago period's results include a non-cash charge related to U.S. tax reform of $7.3 billion.

Excluding items, adjusted earnings for the quarter were $1.43 per share, compared to $1.65 per share last year. On average, analysts polled by Thomson Reuters expected the company to report earnings of $1.22 per share. Analysts' estimates typically exclude special items.

Net sales and revenue for the quarter increased 1.8 percent to $38.40 billion from $37.72 billion in the year-ago period. Wall Street expected revenues of $36.48 billion.

GM's adjusted earnings before interest and taxes or adjusted EBIT decreased 8.3 percent to $2.83 billion from $3.09 billion last year.

In North America, GM reported adjusted EBIT of $3.04 billion, up from $2.88 billion in the year-ago period, reflecting the strength of the company's full-size truck franchise and ongoing cost discipline that helped offset commodity headwinds and downtime volume impact.

Through December 31, 2018, GM sold 8.4 million vehicles globally, down 12.7 percent from the prior year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
Follow RTT
>